Vaccine News and Research

Latest Vaccine News and Research

Biomira and Merck announce fast track status for liposome vaccine

Biomira and Merck KGaA have announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track status to the investigation of BLP25 Liposome Vaccine (L-BLP25) for its proposed use in the treatment of non-small cell lung cancer (NSCLC).

29 Sep 2004

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Scientists at the University of Aberdeen have been awarded £196,166 to help fund pioneering research, which is exploring a method of combating certain conditions and diseases such as asthma and multiple sclerosis.

29 Sep 2004

Last year over 36,000 Americans died from exposure to the flu

Another 200,000 people were hospitalized with symptoms of the illness. The flu and pneumonia (the most common complication of the flu) combined are the fifth leading cause of death among Americans age 65 and older.

29 Sep 2004

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."

28 Sep 2004

Outbreak of whooping cough in South Australia

South Australia's Department of Health is urging parents to make sure their children are immunised against whooping cough as an outbreak is beginning in SA.

28 Sep 2004

Hong Kong influenza vaccination to start November

Six groups of people at higher risk of flu complications will make up the first category in the Hong Kong Government's Influenza Vaccination Programme, to be implemented in November and December.

27 Sep 2004

CDC reports that too few young children are protected against influenza

A report issued by the Centers for Disease Control and Prevention (CDC) estimates that only 4.4 percent of the nation’s children aged 6 to 23 months were fully vaccinated against influenza during the 2002-03 influenza season, the first season CDC encouraged influenza vaccination for healthy children.

26 Sep 2004

Study presents multiple lines of evidence against the proposed link between SV40 and human mesotheliomas

Mesothelioma is an aggressive cancer of the chest cavity that kills about 2000 people a year in the United States.

26 Sep 2004

Allow genomic information to be freely available on the internet

This week’s lead editorial in THE LANCET discusses the benefits and potential risks of allowing genomic information to be freely available on the internet

23 Sep 2004

American Lung Association launches online flu shot locator

As the flu season is about to begin, the American Lung Association today launched its online "flu shot locator" to help more people find and obtain flu vaccinations in their neighborhoods.

23 Sep 2004

Potential new way to control drug-resistant bacteria

The researchers, who encountered this genetic property while working on an unrelated project, believe that this discovery could lead to the use of genetically engineered phages to treat bacterial infections that have become resistant to antibiotics.

23 Sep 2004

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Gaur acid is a natural skin secretion of the gaur, an Asian wild ox. Preliminary evidence suggests that this chemical discourages the landing and feeding of Aedes aegypti, a common mosquito that carries and transmits the yellow fever virus in some parts of the world.

23 Sep 2004

Whooping cough at highest levels since 1997 in Western Australia

Western Australia is experiencing the highest level of whooping cough (pertussis) notifications since 1997, when more than 1200 cases were notified.

22 Sep 2004

Edible vaccine for HIV AIDS

Scientists from Novosibirsk are engaged in the development of an unusual vaccine which, apart from being less expensive to produce, safe and painless to administer, is also edible.

22 Sep 2004

Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine

HHS Secretary Tommy G. Thompson has announced the awarding of a contract to Aventis Pasteur Inc. to manufacture and store 2 million doses of avian influenza H5N1 vaccine

22 Sep 2004

Streptococcus bacteria uses sword and shield to fight white blood cells

A single gene called cylE within the important bacterial pathogen Group B Streptococcus (GBS), controls two factors that act together as a “sword” and “shield” to protect the bacteria from the killing effects of the immune system’s white blood cells

21 Sep 2004

Scientists decipher genetic code of ancient pathogen that causes the horse disease

More than 2,400 years after Hippocrates, the Greek physician born in 460 BC first described the symptoms of glanders, scientists have deciphered the genetic code of the ancient pathogen that causes the horse disease: Burkholderia mallei.

20 Sep 2004

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to kill people in the prime of life and burden health systems with chronically sick people unless childhood immunization against hepatitis B is stepped up

20 Sep 2004

Genome researchers to look at 1918 Spanish flu

University of Washington researchers will be taking part in a multi-site project examining a portion of the genome of the strain of influenza responsible for the "Spanish Flu" outbreak in 1918.

20 Sep 2004

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® technology.

20 Sep 2004

Vaccine News and Research

Latest Vaccine News and Research

Biomira and Merck announce fast track status for liposome vaccine

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Last year over 36,000 Americans died from exposure to the flu

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Outbreak of whooping cough in South Australia

Hong Kong influenza vaccination to start November

CDC reports that too few young children are protected against influenza

Study presents multiple lines of evidence against the proposed link between SV40 and human mesotheliomas

Allow genomic information to be freely available on the internet

American Lung Association launches online flu shot locator

Potential new way to control drug-resistant bacteria

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Whooping cough at highest levels since 1997 in Western Australia

Edible vaccine for HIV AIDS

Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine

Streptococcus bacteria uses sword and shield to fight white blood cells

Scientists decipher genetic code of ancient pathogen that causes the horse disease

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Genome researchers to look at 1918 Spanish flu

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in